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ABSTRACT 
Our objective was to investigate the relationship between 
body mass index (BMI), waist/hip ratio (WHR), for- 
Iicle-stimulating hormone (FSH) dose, length ofstimula- 
tion and clinical outcome in infrtile women with and 
without polycystic ovary syndrorne ( P C O S )  undergoing 
corztrolled ovarian hyperstimulation. 
Controlled ovarian hyperstimulation was induced in 
60 women for a total of 1 1  1 cycles (48% in P C O S  
patients) with urinary huinan FSH (u-hFSH).  
A s<qn$cant correlation between BMI, u-hFSH dose 
and duration of stimulation was found in PCOS and 
non-PCOS patients with WHR < 0.8. These correla- 
tions were not present in P C O S  patients with WHR 
> 0.8.  Pregnant patients received signijcantly Iess am- 
From o w  data we sii'gest a controlled ovarian hyper- 
s t i rdat ion  protocol, for obese non-PCOS patients and 
obese PCOS patients with WHR 0.8, starting with 
a double dose ofir-FSH. 
yules c$lr-hFSH. 
INTRODUCTION 
The use of carefully controlled ovarian hyper- 
stimulation, either in combination with artificial 
insemination with the partner's semen or not, has 
been employed with good results in infertile 
couples with anovulatory , mild endometriosis and 
unexplained infertility'-'. 
The  production of two to four follicles by 
gonadotropin stimulation plays a key role in in- 
creasing the rate of single or twin pregnancies 
without dangerously raising the rate of multiple 
pregnancies (more than twins) and ovarian hyper- 
stimulation syndrome (OHSS)'. Therefore, to this 
aim, it would be extremely useful to assess which 
are the factors influencing the ovarian response to 
induction of multiple follicular development in 
terms of gonadotropin requirement, starting dose 
and length of stimulation. Among these variables, 
body weight and body-fat distribution represent 
two important and easily assessed pararneters for 
consideration. 
~ ~~ ~ 
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I r i t i c w i .  i t  hn,i becii shown that obese women  
i-c~iuirc higher doses of gonadotropin o r  
c.Ioinip1iciic citratc to  achieve an optimal ovarian 
rcipotise t o  stiniulntion4-" and, recently, increasing 
i . v , t i d l i i p  i - n t i o  has been s h o w n  t o  be relatively 
,iswc-i.itc:ii with the probability of  conception per 
;!;cIc ' .  Morcovcr, a direct correlation was found 
lict\vec.ii gonadotropin requirement and body 
\\.tight ti11 the induction o f  niultiple follicular 
d t ~  c'lopiiicritY~''. Ho\vever, other authors have 
L i i I t d  t o  o i l t i r i n  thcsc data"'. 
I ! ici.c:i~d body Lveiglit and hypcrandrogenisni 
( ~ o i i i i i i o i i  feature\ ainong anovulatory wonien 
\t it11 y o l ~ ~ c y ~ t i ~ ~  o w r y  syndrome (PCOS), and 
Ii~,~pi.r,iiidrcigc~iiisiii is known t o  be associated with 
, i l [ L ~ c : d  o\ 'c i r ia> rcsponsivencss to gonadotropin 
, t i i i i t i L i t i o i i " .  
i$oti). E i t  distribution provides a reliable estimate 
c i f . i i i t i i . o ~ i . i i i ~ a t i ( i i i  n  w o i i i c ~ i ' : ' ~ ~ ~ .  Therefore, con- 
\iiicv-iiiS t j i c '  6-cqwnt  association between obesity 
; i ~ i t l  . i iitirct~ciii~ation i i i PCOS patients, w e  under- 
t o o k  , I  \ t i d y  to investigate whether there is a 
c c ~ r - i x ~ l a t i o n  lwt\vccii body mass index (BMI) and 
T ~ < i r ! o i i \  p.ir,inictcrs of controlled ovarian hyper- 
~ : i i i i ~ i I , m ~ ~ i ~  :is '1 fi nction of  body fat distribution. 
MATERIALS AND METHODS 
' s ixty liifcrtilc p t i en t s ,  aged 25-37 years 
( i i i i * < i i i  zk SI), 30.4 rt 5.3) wcre included in the 
\[t idy J'lic. niean duration o f  infertility was 
4.1 C 2.4 y c m .  7'~llxtl infertility arid iiiale factor 
7 , ~  crc' c.sc-liictcd 
I' : i i i i ' i i ty ic'crc divided into two groups: normo- 
o ~ ~ i i I t i t ( i i - ~ ~  : i i i d  I'COS. Patients wcre defined as 
, i t i C c - t c d  by  I'(:OS when presenting an ultrasono- 
g i ~ ' i p l i i c .  pittcrii ofpolycystic ovaries (niore than ten 
! d l ~ ~ ~ k ~ \  i ,iiigiiig from 2 t o  8 n in i  in diameter in  the 
\uix~bip\t i l : ir  rcgion of the ovarian cortex; the ovar- 
1.111 ~ t r o i ~ t ; ~  i s  expandcd and cchogenic; the whole 
~ .o l~ i r i i c  I \  grc.itcr tlinn 9 nil) together with one o r  
i i i ( > i . c '  (it' die syiiiptoins characteristic of  the syn- 
c i n l i i i c  ( o l i ~ o - n ~ ~ i ~ i i ~ ~ r r l i c ~ i ,  anovulation, hirsutisni, 
J < . I I C .  c>hcsity) ''.I5. 
All p.iticiit< uiidcrwcnt controlled ovarian hy- 
~ " i . ' f i i i i 1 i l ; i t i o i i  hllowed either by timed inter- 
i o u i - x .  o r  b y  intraiitcrine and/or intrapcritoneal 
i l t \ c v i i i i i , i t i o i i  nfter scnicn pwparatioii'". The con- 
i 7 -c ) l l c%if  ov:iri~i> liypcrsttiniulatiori protocol started 
\ \  i t 1 1  t l ic-  ~idniinistration of 75 IU ofurinary huinan 
ti i I I i t. I c- \ t i 1 I 1 II 1 ;it I 11 g h oriii on e ( LI -hFSH ; Metro  di n, 
Serono, Italy) daily for 7 day\. The dow w a s  
doubled after 7 day5 in the absence of ovarim 
response and then every 3 days in \tcp-up fashion 
Monitoring was performed by t r m s v a g d  ul- 
trasonography using a 5-mHz transducer attac hcd 
to an Aloka sector scanner, and by serum cstr'idio' 
evaluation. Both ultrasound ex~iiiinations and 
estradiol determinations were performed after thc 
first 7 days of  treatment and then every 3 day\. 
Estradiol levels were measured by radloinimunoav- 
(ay (KIA) using a commercial kit (Iladiin, R o m e .  
Italy) 
H u m a n  chorionic gonadotropin (hCC;, Profav, 
Serono, Italy) 10 000 units w a s  ~ciiiiini\tere~i 
when one  to four (2nd n o  inore than four) fol- 
licles reached a minimum diameter of 1 X ~ i i i i i  
in the presence ofserum estradiol level5 of between 
200 and 1500 pg/inl per follicle > 15 i i i i i i  Ovula- 
tion was assessed by ultrasonographlc nionitoring 
and serum progesterone evaluation 
I n  all cycles, the following paraiiicters we1 i 
evaluated: patient BMI, calculated by the r ~ t i o  f  
body weight (kg) divided by the height' (in'), 
patient w a i d h i p  ratio (WHII), cAculatcd 13) tl:c 
ratio ofwaist circunifcrence inca\ured 'it tlic unibil - 
icus divided by hip circu~iiferciicc (ciii) iiieasurc ti 
at the largest measurement of tlic hips, number [if 
ampules of  u-hFSH adniinistered, ovu1,ition rntc, 
and pregnancy rate 
Statistical analysis was performed tn l 'e~ir~on ' \  
test, X' and Student's test whcn dppropriatc 
RESULTS 
An overall sunimary  of the c l i n i ~ a l  o ~ i t c o i ~ i c  I\ 
presented in Table 1. T h e  total  iiuiiibc~r of 5 t i i i i t i -  
lated cycles w a s  11 1 The o\~erall ov~i l~ i t ion  ratc .I\ 
90 l ( j / ( l O O / 1 1 1 ) a n d t h ~ p r ~ g i i ~ i i c ~  rcitema\ 17 1 %  
(19/111) Among the 39 prcgn,uiciec, thrcc 
(15.8%) wcre twin There  wcrc i i o  liigher riiulti- 
ples (triplets o r  above) o r  any C J ~  of-m ere O H j \  
T h e  niean BMI was 25 4 F 3 6 (rcingc 18 7- 
34 6), the ~ n e ~ i i  nunibcr of L I - ~ F S H  .iiiipulcs \\'I) 
12 6 t- 4.1 (range 0 5-42 0), m d  the liieclli durCition 
of stimulation wa\ 12 4 d+\  +_ 2 5 (range X-3i) 
BMI was found to be significantly correlnted \\ i t h  
both the number of  LI-hFSH ,iiiipulcs .idmini\t 
and the length of  stiiiiulatioii ( I  = 0 380.3, 
p < 0.001 and Y = 0 4561.11 < 0 001 , r e y m  ti \  ci\) 
Fifty-eight cycles (52 3'X) were induccd i n  1 1 0 1 1 -  
PCOS patients Among tlicw piticiits the i i i c  in 
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Table 1 Clinical outcome of 60 patients with induced controlled ovarian hyperstimulation 
PCOS 
All patients Non-PCOS WHR < 0.8 WHR > 0.8 
Cycles 111 58 19 34 
Ovulatory cycles 100 (90.2%) 58 (100%) 17 (89.4%) 25 (73.5%) 
Peak estradiol (pg/ml) (mean f SD) 512 f 194 419 f 162 512 k 172 632 f 214 
Follicles > 18 nim at hCG administration 
(mean f SD) 1.6 f 0.4 1 . 4 f 0 . 3  2.0 f 0.6 1 . 8 f 0 . 5  
Pregnancies 19 (17.1%) 9 (15.5%) 4 (21.1%) 6 (17.6%) 
13.9 f 5.9 u-hFSH ampules administered 
Duration of stimulation (days) 12 .4 f2 .5  12 .4 f2 .0  *1 10 .8 f2 .0  13 .2 f3 .2  
Body mass index (kg/ni') 25.4k3.61:  24.1k3.1 J f  24.754.21:  28.1k2.5 
PCOS, polycystic ovarian syndrome; WHR, waist/hip ratio; hCG, human chorionic gonadotropin; u-hFSH, uri- 
nary human follicle-stimulating hormone; * variables significantly correlated (p < 0.001) 
1 10.9 k 2.7 1 12.7 f 2.8 1 12.6 f 4.1 
BMI was 24.1 f 3.1 (range 18.7-30.0), the mean 
number of u-hFSH ampules was 12.7 f 2.8 (range 
9-21) and the mean duration of stimulation was 
12.4 f 2.0 (range 9.0-18.0). The ovulation rate 
was 100% (58/58) and the pregnancy rate was 
15.5% (9/58). BMI was again found to be signifi- 
cantly correlated with both the number ofu-hFSH 
ampules administered and the length ofstimulation 
( Y =  0.5788, p < 0.001 and r = 0.5766, p < 0.001, 
respectively). 
Fifty-three cycles (47.7%) were induced in 
patients with PCOS. Among these, 19 cycles were 
induced in patients with a WHR < 0.8 and 34 
cycles were inducedin patients with a WHR > 0.8. 
In the PCOS patients with W H K  < 0.8, the 
ovulation rate was 89.4% (17/19) and the preg- 
nancy rate was 21.1% (4/19). The mean BMI was 
24.7 f 4.2 (range 19-32.8), the mean number of 
u-hFSH ampules administered was 10.9 f 2.7 
(range 6.5-16) and the mean duration of stimula- 
tion was 20.8 f 2.0 days (range 8.0-14.0). In this 
restricted group of patients, BMI was found to 
be significantly correlated with both number 
of u-hFSH ampules administered (r = 0.8467, 
p < 0.001) and length of Stimulation (r = 0.8668, 
In the PCOS patients with WHK > 0.8 the 
ovulation rate was 73.5% (25/34) and the preg- 
nancy rate was 17.6% (6/34). No significant differ- 
ence was detected in the ovulation rate and 
pregnancy rate between PCOS patients with 
W H R  < 0.8 and PCOS patients with WHR 
> 0.8. The mean BMI was 28.1 f 2.5 (range 25- 
34.6), the mean number of u-hFSH ampules was 
13.9 k 5.9 (range 7-42) and thc mean duration of 
p < 0.001). 
stimulation was 13.2 f 3.2 days (range 8-25). In 
this group ofpatients it was not possible to demon- 
strate any significant correlation ofBMI either with 
the number of u-hFSH ampules administered 
(r = 0.1343), or with the length of stimulation 
(r = 0.0913). 
No statistically significant difference was de- 
tected among non-PCOS women, PCOS women 
with WHR > 0.8 and PCOS patients with W H R  
< 0.8, in the number of u-hFSH ampules, in the 
length of stimulation, in the number of mature 
follicles at hCG administration and in the peak 
estradiol serum levels. However, we observed a 
mean number of u-hFSH ampules and days of 
stimulation significantly lower (p < 0.05) in cycles 
leading to pregnancy than in unsuccessfiil cycles. 
DISCUSSION 
Weight and body mass are known to be important 
parameters in determining the potential of a 
woman's reproductive system" but their influence 
on ovarian response to exogenous gonadotropins 
is still contr~versial"~~~~'" .  
Our data confirm a significant inverse correla- 
tion between BMI and ovarian response to 
gonadotropin (expressed as u-hFSH ampules and 
length of stimulation) at least in normo-ovulatory 
patients and in women with PCOS and WHR 
< 0.8. This correlation was not found in PCOS 
patients with a central-type body fat distribution. 
Previous papers on this subject seem to show 
that reduced ovarian sensitivity to exogenous 
gonadotropins in obese patients is not related to 
different absorption and distribution of the drug18, 
Gynecological Endocrinology 19 
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lwt  iould be better explained by altered hy- 
p o t l i A a i i i c  ncuromodul'itioii and/or peripheral 
?[crc)id iiietabohsni' T h e  lack of correlation in 
piticiit\ with I'COS aid WHR > 0 8 is probably 
c \pI,uiicd by the intraovarian interferences of the 
i i i ~ r e ~ ~ c c i  fi i-c mdrogeii levels and insulin rc- 
\ I> t . inc  c Indeed, it h,n been h o w n  that both these 
c o i i d i t i o i i \  arc pregcnt i i i  this subpopulation of 
in  I T (  >S ~ ~ o n i e n ,  hyperaitdrogenisni has bcen 
c 1,iiiiicd to be caused by a primitive insulin-re- 
k i m i i c  c' with wcoiic1a-y hyperinsulinism. T h e  in- 
4 I C J ~ I  i n d n  level\, together with a reduction in 
t l i L .  hiriding pi oteinj  for insulin-like growth factor 
I BP-I), inight x t  on the ovarian theca IGF-I 
s ing  the rcsponuveness of the fol- 
l i t  le t o  luteinitiiig hormoiic (LH)". 
t rcliii thew Lonsiderdtions, we hypothesize that 
111 o i i i  1)COS patient? with WHR > 0.8, the nie- 
1 ~ h 0 1 i ~  di?turbdnce charactcriG,tic of the syndrome, 
c . I L I \ C \ ~  ~ i i  inLi c'asc 111 the follicular response to FSH 
~ t l i i i  h I \  m,i\kcd, up to an '1s yet undetermined 
point b\ the negative effect on folliculogencsis 
<\ i  rted by  thc  iiicrcdwd androgen levels". W h e n  
~ ~ ~ ~ l ~ c i ~ l . ~ ~  ckw~lopnicnt 1 5  \ct in motion by exo- 
<Cll<lLi?  FSH, the incre'iscd sensitivity IS then un- 
I'C 0 5  p'l t lcntP 2 ' .  
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